LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,521
تعداد دریافت فایل اصل مقاله11,291,330
Mashhouri, Siavash, Abtahi Froushani, Seyyed Meysam, Tehrani, Ali Asghar. (1399). Non-Adherent Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Clinical Manifestations and Inflammation in an Experimental Model of Ulcerative Colitis in Rats. سامانه مدیریت نشریات علمی, 45(5), 341-351. doi: 10.30476/ijms.2020.72514.0
Siavash Mashhouri; Seyyed Meysam Abtahi Froushani; Ali Asghar Tehrani. "Non-Adherent Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Clinical Manifestations and Inflammation in an Experimental Model of Ulcerative Colitis in Rats". سامانه مدیریت نشریات علمی, 45, 5, 1399, 341-351. doi: 10.30476/ijms.2020.72514.0
Mashhouri, Siavash, Abtahi Froushani, Seyyed Meysam, Tehrani, Ali Asghar. (1399). 'Non-Adherent Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Clinical Manifestations and Inflammation in an Experimental Model of Ulcerative Colitis in Rats', سامانه مدیریت نشریات علمی, 45(5), pp. 341-351. doi: 10.30476/ijms.2020.72514.0
Mashhouri, Siavash, Abtahi Froushani, Seyyed Meysam, Tehrani, Ali Asghar. Non-Adherent Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Clinical Manifestations and Inflammation in an Experimental Model of Ulcerative Colitis in Rats. سامانه مدیریت نشریات علمی, 1399; 45(5): 341-351. doi: 10.30476/ijms.2020.72514.0

Non-Adherent Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Clinical Manifestations and Inflammation in an Experimental Model of Ulcerative Colitis in Rats

Iranian Journal of Medical Sciences
مقاله 4، دوره 45، شماره 5، آذر 2020، صفحه 341-351    اصل مقاله (2.34 M)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2020.72514.0
نویسندگان
Siavash Mashhouri1؛ Seyyed Meysam Abtahi Froushani* 1؛ Ali Asghar Tehrani2
1Department of Microbiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
2Department of Pathobiology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran
چکیده
Background: Functional and developmental versatility of mesenchymal stem cells (MSCs) have generated great interest in their clinical application. Recently, it has been proposed that the non-adherent population of bone marrow cells can differentiate to MSCs in vitro. The present study aimed to compare the anti-inflammatory potentials of adherent and non-adherent MSCs in an experimental model of ulcerative colitis (UC) in rats.
Methods: The present experimental study was conducted at the School of Veterinary Medicine, Urmia University (Urmia, Iran) during March-May 2018. UC was induced using acetic acid in three groups of male Wistar rats, namely the control colitis, adherent MSCs treated, and non-adherent MSCs treated groups. Adherent and non-adherent MSCs were collected, characterized, and proliferated. The isolated cells were injected into the peritoneum of the respective groups of colitis rats. After 10 days, the animals were evaluated for gross and microscopic pathology, production of inflammatory mediators, and stress oxidative profile in the gut tissue. The statistical analysis was performed using SPSS software (version 23.0). p Results: The non-adherent MSCs had almost similar therapeutic potency compared to the adherent MSCs (P=0.12). They significantly reduced the level of inflammatory mediators and improved the oxidative stress profile in colonic tissue compared to the control colitis group (P=0.0001).
Conclusion: The molecular assays and histopathological assessment revealed that the non-adherent MSCs not only had anti-inflammatory and regulatory potency but also enhanced tissue regeneration in UC rats. Therefore, the non-adherent fraction of bone marrow-derived MSCs could be used as a complementary source of MSCs in stem cell therapies.
کلیدواژه‌ها
Mesenchymal stem cells؛ Colitis؛ Inflammation؛ Oxidative stress
سایر فایل های مرتبط با مقاله
مراجع
  1. Abbasi A, Kukia NR, Froushani SMA, Hashemi SM. Nicotine and caffeine alter the effects of the LPS- primed mesenchymal stem cells on the co-cultured neutrophils. Life Sci. 2018;199:41-7. doi: 10.1016/j.lfs.2018.03.009. PubMed PMID: 29518399.
  2. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230-47. PubMed PMID: 5654088.
  3. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol. 1974;2:83-92. PubMed PMID: 4455512.
  4. Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35. doi: 10.1042/BSR20150025. PubMed PMID: 25797907; PubMed Central PMCID: PMCPMC4413017.
  5. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2008;2:313-9. doi: 10.1016/j.stem.2008.03.002. PubMed PMID: 18397751; PubMed Central PMCID: PMCPMC2613570.
  6. Friedenstein AJ, Latzinik NV, Gorskaya Yu F, Luria EA, Moskvina IL. Bone marrow stromal colony formation requires stimulation by haemopoietic cells. Bone Miner. 1992;18:199-213. doi: 10.1016/0169-6009(92)90807-p. PubMed PMID: 1392694.
  7. Wu Y, Zhang J, Ben X. Neuronal-like cell differentiation of non-adherent bone marrow cell-derived mesenchymal stem cells. Neural Regen Res. 2013;8:2078-85. doi: 10.3969/j.issn.1673-5374.2013.22.007. PubMed PMID: 25206516; PubMed Central PMCID: PMCPMC4146062.
  8. Zheng RC, Kim SK, Heo SJ, Koak JY, Lee JH, Park JM. Characteristics and response of mouse bone marrow derived novel low adherent mesenchymal stem cells acquired by quantification of extracellular matrix. J Adv Prosthodont. 2014;6:351-60. doi: 10.4047/jap.2014.6.5.351. PubMed PMID: 25352957; PubMed Central PMCID: PMCPMC4211051.
  9. Stolzing A, Bauer E, Scutt A. Suspension cultures of bone-marrow-derived mesenchymal stem cells: effects of donor age and glucose level. Stem Cells Dev. 2012;21:2718-23. doi: 10.1089/scd.2011.0406. PubMed PMID: 22462498.
  10. Zhang Y, Fan Y, Wang Z, Wan Y, Zhou Z, Zhong B, et al. Isolation, characterization, and gene modification of dairy goat mesenchymal stem cells from bone marrow. In Vitro Cell Dev Biol Anim. 2012;48:418-25. doi: 10.1007/s11626-012-9530-z. PubMed PMID: 22806970.
  11. Zhang ZL, Tong J, Lu RN, Scutt AM, Goltzman D, Miao DS. Therapeutic potential of non-adherent BM-derived mesenchymal stem cells in tissue regeneration. Bone Marrow Transplant. 2009;43:69-81. doi: 10.1038/bmt.2008.260. PubMed PMID: 18711348.
  12. Esmaili Gourvarchin Galeh H, Meysam Abtahi Froushani S, Afzale Ahangaran N, Hadai SN. Effects of Educated Monocytes with Xenogeneic Mesenchymal Stem Cell-Derived Conditioned Medium in a Mouse Model of Chronic Asthma. Immunol Invest. 2018;47:504-20. doi: 10.1080/08820139.2018.1458108. PubMed PMID: 29671652.
  13. Meier J, Sturm A. Current treatment of ulcerative colitis. World J Gastroenterol. 2011;17:3204-12. doi: 10.3748/wjg.v17.i27.3204. PubMed PMID: 21912469; PubMed Central PMCID: PMCPMC3158396.
  14. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307-17. doi: 10.1038/nature10209. PubMed PMID: 21677747; PubMed Central PMCID: PMCPMC3204665.
  15. Dave M, Mehta K, Luther J, Baruah A, Dietz AB, Faubion WA, Jr. Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2015;21:2696-707. doi: 10.1097/MIB.0000000000000543. PubMed PMID: 26230863; PubMed Central PMCID: PMCPMC4615553.
  16. Hu J, Zhao G, Zhang L, Qiao C, Di A, Gao H, et al. Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis. Exp Ther Med. 2016;12:2983-9. doi: 10.3892/etm.2016.3724. PubMed PMID: 27882104; PubMed Central PMCID: PMCPMC5103734.
  17. Low D, Nguyen DD, Mizoguchi E. Animal models of ulcerative colitis and their application in drug research. Drug Des Devel Ther. 2013;7:1341-57. doi: 10.2147/DDDT.S40107. PubMed PMID: 24250223; PubMed Central PMCID: PMCPMC3829622.
  18. Karimi H, Emami SA, Olad-Gubad MK. Bone Marrow Stem Cells and Ear Framework Reconstruction. J Craniofac Surg. 2016;27:2192-6. doi: 10.1097/SCS.0000000000003146. PubMed PMID: 28005788.
  19. Wan C, He Q, McCaigue M, Marsh D, Li G. Nonadherent cell population of human marrow culture is a complementary source of mesenchymal stem cells (MSCs). J Orthop Res. 2006;24:21-8. doi: 10.1002/jor.20023. PubMed PMID: 16419965.
  20. Shushtari N, Abtahi Froushani SM. Caffeine Augments The Instruction of Anti-Inflammatory Macrophages by The Conditioned Medium of Mesenchymal Stem Cells. Cell J. 2017;19:415-24. doi: 10.22074/cellj.2017.4364. PubMed PMID: 28836403; PubMed Central PMCID: PMCPMC5570406.
  21. Noronha-Blob L, Lowe VC, Muhlhauser RO, Burch RM. NPC 15669, an inhibitor of neutrophil recruitment, is efficacious in acetic acid-induced colitis in rats. Gastroenterology. 1993;104:1021-9. doi: 10.1016/0016-5085(93)90269-i. PubMed PMID: 8385041.
  22. Al-Rejaie SS, Abuohashish HM, Al-Enazi MM, Al-Assaf AH, Parmar MY, Ahmed MM. Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats. World J Gastroenterol. 2013;19:5633-44. doi: 10.3748/wjg.v19.i34.5633. PubMed PMID: 24039355; PubMed Central PMCID: PMCPMC3769899.
  23. Pulli B, Ali M, Forghani R, Schob S, Hsieh KL, Wojtkiewicz G, et al. Measuring myeloperoxidase activity in biological samples. PLoS One. 2013;8:e67976. doi: 10.1371/journal.pone.0067976. PubMed PMID: 23861842; PubMed Central PMCID: PMCPMC3702519.
  24. Bryan NS, Grisham MB. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic Biol Med. 2007;43:645-57. doi: 10.1016/j.freeradbiomed.2007.04.026. PubMed PMID: 17664129; PubMed Central PMCID: PMCPMC2041919.
  25. Al-Rejaie SS, Aleisa AM, Sayed-Ahmed MM, Al-Shabanah OA, Abuohashish HM, Ahmed MM, et al. Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Westar rat. BMC Complement Altern Med. 2013;13:136. doi: 10.1186/1472-6882-13-136. PubMed PMID: 23773725; PubMed Central PMCID: PMCPMC3717094.
  26. Gao Y, Huang Y, Zhao Y, Hu Y, Li Z, Guo Q, et al. LL202 protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting MAPK/AP-1 signaling. Oncotarget. 2016;7:63981-94. doi: 10.18632/oncotarget.11742. PubMed PMID: 27590510; PubMed Central PMCID: PMCPMC5325419.
  27. Orsonneau JL, Douet P, Massoubre C, Lustenberger P, Bernard S. An improved pyrogallol red-molybdate method for determining total urinary protein. Clin Chem. 1989;35:2233-6. PubMed PMID: 2582622.
  28. Dave M, Mehta K, Luther J, Baruah A, Dietz AB, Faubion WA, Jr. Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2015;21:2696-707. doi: 10.1097/MIB.0000000000000543. PubMed PMID: 26230863; PubMed Central PMCID: PMCPMC4615553.
  29. Fawzy SA, El-Din Abo-Elnou RK, Abd-El-Maksoud El-Deeb DF, Yousry Abd-Elkader MM. The possible role of mesenchymal stem cells therapy in the repair of experimentally induced colitis in male albino rats. Int J Stem Cells. 2013;6:92-103. doi: 10.15283/ijsc.2013.6.2.92. PubMed PMID: 24386553; PubMed Central PMCID: PMCPMC3878209.
  30. Castelo-Branco MT, Soares ID, Lopes DV, Buongusto F, Martinusso CA, do Rosario A, Jr., et al. Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. PLoS One. 2012;7:e33360. doi: 10.1371/journal.pone.0033360. PubMed PMID: 22432015; PubMed Central PMCID: PMCPMC3303821.
  31. Sala E, Genua M, Petti L, Anselmo A, Arena V, Cibella J, et al. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine. Gastroenterology. 2015;149:163-76. doi: 10.1053/j.gastro.2015.03.013. PubMed PMID: 25790743.
  32. Cagin YF, Parlakpinar H, Vardi N, Polat A, Atayan Y, Erdogan MA, et al. Effects of dexpanthenol on acetic acid-induced colitis in rats. Exp Ther Med. 2016;12:2958-64. doi: 10.3892/etm.2016.3728. PubMed PMID: 27882101; PubMed Central PMCID: PMCPMC5103730.
  33. Randhawa PK, Singh K, Singh N, Jaggi AS. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol. 2014;18:279-88. doi: 10.4196/kjpp.2014.18.4.279. PubMed PMID: 25177159; PubMed Central PMCID: PMCPMC4146629.
  34. Song JY, Kang HJ, Hong JS, Kim CJ, Shim JY, Lee CW, et al. Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages. Sci Rep. 2017;7:9412. doi: 10.1038/s41598-017-09827-5. PubMed PMID: 28842625; PubMed Central PMCID: PMCPMC5573412.
  35. Inan M, Bakar E, Cerkezkayabekir A, Sanal F, Ulucam E, Subasi C, et al. Mesenchymal stem cells increase antioxidant capacity in intestinal ischemia/reperfusion damage. J Pediatr Surg. 2017;52:1196-206. doi: 10.1016/j.jpedsurg.2016.12.024. PubMed PMID: 28118930.
  36. Tian T, Wang Z, Zhang J. Pathomechanisms of Oxidative Stress in Inflammatory Bowel Disease and Potential Antioxidant Therapies. Oxid Med Cell Longev. 2017;2017:4535194. doi: 10.1155/2017/4535194. PubMed PMID: 28744337; PubMed Central PMCID: PMCPMC5506473.
  37. Gong W, Guo M, Han Z, Wang Y, Yang P, Xu C, et al. Mesenchymal stem cells stimulate intestinal stem cells to repair radiation-induced intestinal injury. Cell Death Dis. 2016;7:e2387. doi: 10.1038/cddis.2016.276. PubMed PMID: 27685631; PubMed Central PMCID: PMCPMC5059875.
  38. Strober W, Fuss IJ. Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology. 2011;140:1756-67. doi: 10.1053/j.gastro.2011.02.016. PubMed PMID: 21530742; PubMed Central PMCID: PMCPMC3773507.
  39. Kyurkchiev D, Bochev I, Ivanova-Todorova E, Mourdjeva M, Oreshkova T, Belemezova K, et al. Secretion of immunoregulatory cytokines by mesenchymal stem cells. World J Stem Cells. 2014;6:552-70. doi: 10.4252/wjsc.v6.i5.552. PubMed PMID: 25426252; PubMed Central PMCID: PMCPMC4178255.
آمار
تعداد مشاهده مقاله: 3,450
تعداد دریافت فایل اصل مقاله: 2,670


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب